{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:12:01Z","timestamp":1792800721488,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T00:00:00Z","timestamp":1676937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T00:00:00Z","timestamp":1676937600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"FOREUM Foundation for Research in Rheumatology","id":[{"id":"https:\/\/ror.org\/04jt60909","id-type":"ROR","asserted-by":"crossref"}]},{"name":"IRCCS Istituto Giannina Gaslini","id":[{"id":"https:\/\/ror.org\/0424g0k78","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000780","name":"European Union","doi-asserted-by":"crossref","award":["260353"],"award-info":[{"award-number":["260353"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Rheumatol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Little is known about the association between juvenile idiopathic arthritis (JIA) and autoimmune thyroid disease (AITD) and therefore there are no indications for AITD screening in this population, which is possible using standard blood tests. The objective of this study is to determine the prevalence and predictors of symptomatic AITD in JIA patients from the international Pharmachild registry.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Occurrence of AITD was determined from adverse event forms and comorbidity reports. Associated factors and independent predictors for AITD were determined using univariable and multivariable logistic regression analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The prevalence of AITD after a median observation period of 5.5\u2009years was 1.1% (96\/8965 patients). Patients who developed AITD were more often female (83.3% vs. 68.0%), RF positive (10.0% vs. 4.3%) and ANA positive (55.7% vs. 41.5%) than patients who did not. AITD patients were furthermore older at JIA onset (median 7.8\u2009years vs. 5.3\u2009years) and had more often polyarthritis (40.6% vs. 30.4%) and a family history of AITD (27.5% vs. 4.8%) compared to non-AITD patients. A family history of AITD (OR\u2009=\u20096.8, 95% CI: 4.1 \u2013 11.1), female sex (OR\u2009=\u20092.2, 95% CI: 1.3 \u2013 4.3), ANA positivity (OR\u2009=\u20092.0, 95% CI: 1.3 \u2013 3.2) and older age at JIA onset (OR\u2009=\u20091.1, 95% CI: 1.1 \u2013 1.2) were independent predictors of AITD on multivariable analysis. Based on our data, 16 female ANA positive JIA patients with a family history of AITD would have to be screened during \u00b15.5\u2009years using standard blood tests to detect one case of AITD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This is the first study to report independent predictor variables for symptomatic AITD in JIA. Female ANA positive JIA patients with positive family history are at increased risk of developing AITD and thus might benefit from yearly serological screening.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12969-023-00802-1","type":"journal-article","created":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T18:02:42Z","timestamp":1677002562000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Juvenile idiopathic arthritis patients with positive family history of autoimmune thyroid disease might benefit from serological screening: analysis of the international Pharmachild registry"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8766-6694","authenticated-orcid":false,"given":"Joeri W.","family":"van Straalen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie","family":"Baas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Giancane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyudmila","family":"Grebenkina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jurgen","family":"Brunner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Vega-Cornejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vyacheslav G.","family":"Chasnyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liora","family":"Harel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Appenzeller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Gervais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sytze","family":"de Roock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nico M.","family":"Wulffraat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolino","family":"Ruperto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost F.","family":"Swart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the Paediatric Rheumatology International Trials Organisation (PRINTO)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,21]]},"reference":[{"key":"802_CR1","doi-asserted-by":"publisher","unstructured":"Martini A, Lovell DJ, Albani S, et al. Juvenile idiopathic arthritis. Nat Rev Dis Primers. 2022;8(1):5. Published 2022 Jan 27. https:\/\/doi.org\/10.1038\/s41572-021-00332-8.","DOI":"10.1038\/s41572-021-00332-8"},{"key":"802_CR2","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.berh.2018.10.004","volume":"32","author":"J Palman","year":"2018","unstructured":"Palman J, Shoop-Worrall S, Hyrich K, McDonagh JE. Update on the epidemiology, risk factors and disease outcomes of juvenile idiopathic arthritis. Best Pract Res Clin Rheumatol. 2018;32:206\u201322.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"802_CR3","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1080\/1744666X.2020.1865157","volume":"17","author":"RJ de Oliveira","year":"2021","unstructured":"de Oliveira RJ, Kishimoto ST, de Souza DP, Fernandes PT, Marini R, Appenzeller S. The importance of transition from pediatric to adult rheumatology care in juvenile idiopathic arthritis. Expert Rev Clin Immunol. 2021;17:155\u201361.","journal-title":"Expert Rev Clin Immunol"},{"key":"802_CR4","first-page":"390","volume":"31","author":"RE Petty","year":"2004","unstructured":"Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, et al. International league of associations for rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004;31:390\u20132.","journal-title":"J Rheumatol"},{"key":"802_CR5","doi-asserted-by":"publisher","first-page":"190","DOI":"10.3899\/jrheum.180168","volume":"46","author":"A Martini","year":"2019","unstructured":"Martini A, Ravelli A, Avcin T, Beresford MW, Burgos-Vargas R, Cuttica R, et al. Toward new classification criteria for juvenile idiopathic arthritis: first steps, pediatric rheumatology international trials organization international consensus. J Rheumatol. 2019;46:190\u20137.","journal-title":"J Rheumatol"},{"key":"802_CR6","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/978-3-319-59963-2_13","volume-title":"Comorbidity Rheum dis","author":"E Del Giudice","year":"2017","unstructured":"Del Giudice E, Swart JF, Wulffraat NM. Juvenile idiopathic arthritis. In: El Miedany Y, editor. Comorbidity Rheum dis: Springer International Publishing; 2017. p. 265\u201388."},{"key":"802_CR7","first-page":"0310","volume":"31","author":"TC Robazzi","year":"2013","unstructured":"Robazzi TC, Adan LF, Pimentel K, Guimar\u00e3es I, Magalh\u00e3es Filho J, Toralles MB, et al. Autoimmune endocrine disorders and coeliac disease in children and adolescents with juvenile idiopathic arthritis and rheumatic fever. Clin Exp Rheumatol. 2013;31:0310\u20137.","journal-title":"Clin Exp Rheumatol"},{"key":"802_CR8","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1093\/rheumatology\/keh531","volume":"44","author":"S Stagi","year":"2005","unstructured":"Stagi S, Giani T, Simonini G, Falcini F. Thyroid function, autoimmune thyroiditis and coeliac disease in juvenile idiopathic arthritis. Rheumatology (Oxford). 2005;44:517\u201320.","journal-title":"Rheumatology (Oxford)"},{"key":"802_CR9","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/BF02893034","volume":"20","author":"M Swain","year":"2005","unstructured":"Swain M, Swain T, Mohanty BK. Autoimmune thyroid disorders\u2014An update. Indian J Clin Biochem. 2005;20:9.","journal-title":"Indian J Clin Biochem"},{"key":"802_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13052-017-0373-9","volume":"43","author":"E Tronconi","year":"2017","unstructured":"Tronconi E, Miniaci A, Pession A. The autoimmune burden in juvenile idiopathic arthritis. Ital J Pediatr. 2017;43:1\u20136.","journal-title":"Ital J Pediatr"},{"key":"802_CR11","first-page":"565","volume":"20","author":"M Alpigiani","year":"2002","unstructured":"Alpigiani M, Cerboni M, Bertini I, D\u2019Annunzio G, Haupt R, Iester A, et al. Endocrine autoimmunity in young patients with juvenile chronic arthritis. Clin Exp Rheumatol. 2002;20:565\u20138.","journal-title":"Clin Exp Rheumatol"},{"key":"802_CR12","doi-asserted-by":"publisher","unstructured":"Lovell DJ, Huang B, Chen C, Angeles-Han ST, Simon TA, Brunner HI. Prevalence of autoimmune diseases and other associated conditions in children and young adults with juvenile idiopathic arthritis. RMD Open. 2021;7(1):e001435. https:\/\/doi.org\/10.1136\/rmdopen-2020-001435.","DOI":"10.1136\/rmdopen-2020-001435"},{"key":"802_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12969-020-00426-9","volume":"18","author":"TA Simon","year":"2020","unstructured":"Simon TA, Harikrishnan GP, Kawabata H, Singhal S, Brunner HI, Lovell DJ. Prevalence of co-existing autoimmune disease in juvenile idiopathic arthritis: a cross-sectional study. Pediatr Rheumatol. 2020;18:1\u201312.","journal-title":"Pediatr Rheumatol"},{"key":"802_CR14","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/978-1-4615-4857-7_8","volume":"455","author":"D Mihailova","year":"1999","unstructured":"Mihailova D, Grigorova R, Vassileva B, Mladenova G, Ivanova N, Stephanov S, et al. Autoimmune thyroid disorders in juvenile chronic arthritis and systemic lupus erythematosus. Adv Exp Med Biol. 1999;455:55\u201360.","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"802_CR15","first-page":"164","volume":"33","author":"L Harel","year":"2006","unstructured":"Harel L, Prais D, Uziel Y, et al. Increased prevalence of antithyroid antibodies and subclinical hypothyroidism in children with juvenile idiopathic arthritis. J Rheumatol. 2006;33(1):164\u20136.","journal-title":"J Rheumatol."},{"key":"802_CR16","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ijpam.2016.04.002","volume":"3","author":"D Alhomaidah","year":"2016","unstructured":"Alhomaidah D, Alsagheir A, Al-Mayouf SM. Coexistence of endocrinopathies in children with rheumatic diseases. Int J Pediatr Adolesc Med. 2016;3:119\u201322.","journal-title":"Int J Pediatr Adolesc Med"},{"key":"802_CR17","first-page":"462","volume":"50","author":"E \u00dcnsal","year":"2008","unstructured":"\u00dcnsal E, \u00d6ren O, Salar K, Makay B, Abac\u0131 A, \u00d6zhan B, et al. The frequency of autoimmune thyroid disorders in juvenile idiopathic arthritis. Turk J Pediatr. 2008;50:462\u20135.","journal-title":"Turk J Pediatr"},{"key":"802_CR18","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1136\/adc.2010.188946","volume":"96","author":"N Ruperto","year":"2011","unstructured":"Ruperto N, Martini A. Networking in paediatrics: the example of the Paediatric rheumatology international trials organisation (PRINTO). Arch Dis Child. 2011;96:596\u2013601.","journal-title":"Arch Dis Child"},{"key":"802_CR19","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1186\/s13075-018-1780-z","volume":"20","author":"J Swart","year":"2018","unstructured":"Swart J, Giancane G, Horneff G, Magnusson B, Hofer M, Alexeeva \u0415, et al. Pharmacovigilance in juvenile idiopathic arthritis patients treated with biologic or synthetic drugs: combined data of more than 15,000 patients from Pharmachild and national registries. Arthritis Res Ther. 2018;20:285.","journal-title":"Arthritis Res Ther"},{"key":"802_CR20","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13075-020-02167-2","volume":"22","author":"G Giancane","year":"2020","unstructured":"Giancane G, Swart JF, Castagnola E, Groll AH, Horneff G, Huppertz H-I, et al. Opportunistic infections in immunosuppressed patients with juvenile idiopathic arthritis: analysis by the Pharmachild safety adjudication committee. Arthritis Res Ther. 2020;22:71.","journal-title":"Arthritis Res Ther"},{"key":"802_CR21","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1037\/a0027127","volume":"17","author":"SI Vrieze","year":"2012","unstructured":"Vrieze SI. Model selection and psychological theory: a discussion of the differences between the Akaike information criterion (AIC) and the Bayesian information criterion (BIC). Psychol Methods. 2012;17:228\u201343.","journal-title":"Psychol Methods"},{"key":"802_CR22","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1080\/17446651.2017.1300525","volume":"12","author":"P Pasala","year":"2017","unstructured":"Pasala P, Francis G. Autoimmune thyroid diseases in children. Expert Rev Endocrinol Metab. 2017;12:129\u201342.","journal-title":"Expert Rev Endocrinol Metab"},{"key":"802_CR23","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1001\/archpedi.162.6.526","volume":"162","author":"A Corrias","year":"2008","unstructured":"Corrias A, Cassio A, Weber G, Mussa A, Wasniewska M, Rapa A, et al. Thyroid nodules and Cancer in children and adolescents affected by autoimmune thyroiditis. Arch Pediatr Adolesc Med. 2008;162:526\u201331.","journal-title":"Arch Pediatr Adolesc Med"},{"key":"802_CR24","doi-asserted-by":"publisher","unstructured":"Aversa T, Lombardo F, Valenzise M, et al. Peculiarities of autoimmune thyroid diseases in children with Turner or Down syndrome: an overview. Ital J Pediatr. 2015;41:39. Published 2015 May 15. https:\/\/doi.org\/10.1186\/s13052-015-0146-2.","DOI":"10.1186\/s13052-015-0146-2"},{"key":"802_CR25","doi-asserted-by":"publisher","first-page":"309","DOI":"10.3389\/fendo.2020.00309","volume":"11","author":"O Admoni","year":"2020","unstructured":"Admoni O, Rath S, Almagor T, Elias-Assad G, Tenenbaum-Rakover Y. Long-term follow-up and outcomes of autoimmune thyroiditis in childhood. Front Endocrinol (Lausanne). 2020;11:309.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"802_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13052-018-0461-5","volume":"44","author":"G Crisafulli","year":"2018","unstructured":"Crisafulli G, Gallizzi R, Aversa T, Salzano G, Valenzise M, Wasniewska M, et al. Thyroid function test evolution in children with Hashimoto\u2019s thyroiditis is closely conditioned by the biochemical picture at diagnosis. Ital J Pediatr. 2018;44:1\u20136.","journal-title":"Ital J Pediatr"},{"key":"802_CR27","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1136\/adc.83.3.207","volume":"83","author":"I Hunter","year":"2000","unstructured":"Hunter I, Greene S, MacDonald T, Morris A. Prevalence and aetiology of hypothyroidism in the young. Arch Dis Child. 2000;83:207.","journal-title":"Arch Dis Child"},{"key":"802_CR28","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/S0140-6736(07)60363-8","volume":"369","author":"A Ravelli","year":"2007","unstructured":"Ravelli A, Martini A. Juvenile idiopathic arthritis. Lancet. 2007;369:767\u201378.","journal-title":"Lancet."},{"key":"802_CR29","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.3201\/eid1011.040367","volume":"10","author":"D Fairweather","year":"2004","unstructured":"Fairweather D, Rose NR. Women and autoimmune diseases. Emerg Infect Dis. 2004;10:2005.","journal-title":"Emerg Infect Dis"},{"key":"802_CR30","doi-asserted-by":"publisher","unstructured":"Emamifar A, Hangaard J, Jensen Hansen IM. Thyroid disorders in patients with newly diagnosed rheumatoid arthritis is associated with poor initial treatment response evaluated by disease activity score in 28 joints-C-reactive protein (DAS28-CRP): An observational cohort study. Medicine (Baltimore). 2017;96(43):e8357. https:\/\/doi.org\/10.1097\/MD.0000000000008357.","DOI":"10.1097\/MD.0000000000008357"},{"key":"802_CR31","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1080\/08916930701620100","volume":"41","author":"F Atzeni","year":"2008","unstructured":"Atzeni F, Doria A, Ghirardello A, Turiel M, Batticciotto A, Carrabba M, et al. Anti-thyroid antibodies and thyroid dysfunction in rheumatoid arthritis: prevalence and clinical value. Autoimmunity. 2008;41:111\u20135.","journal-title":"Autoimmunity"},{"key":"802_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1546-0096-8-15","volume":"8","author":"KS Torok","year":"2010","unstructured":"Torok KS, Arkachaisri T. Autoimmune thyroiditis in antinuclear antibody positive children without rheumatologic disease. Pediatr Rheumatol. 2010;8:1\u20134.","journal-title":"Pediatr Rheumatol"},{"key":"802_CR33","doi-asserted-by":"publisher","unstructured":"Segni M, Pucarelli I, Truglia S, Turriziani I, Serafinelli C, Conti F. High prevalence of antinuclear antibodies in children with thyroid autoimmunity. J Immunol Res. 2014;2014:150239. https:\/\/doi.org\/10.1155\/2014\/150239.","DOI":"10.1155\/2014\/150239"},{"key":"802_CR34","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1080\/17843286.2018.1555115","volume":"75","author":"D Kust","year":"2018","unstructured":"Kust D, Matesa N. The impact of familial predisposition on the development of Hashimoto\u2019s thyroiditis. Acta Clin Belg. 2018;75:104\u20138.","journal-title":"Acta Clin Belg"},{"key":"802_CR35","first-page":"659","volume":"36","author":"M Desai","year":"1999","unstructured":"Desai M, Karandikar S. Autoimmune thyroid disease in childhood: a study of children and their families. Indian Pediatr. 1999;36:659\u201368.","journal-title":"Indian Pediatr"},{"key":"802_CR36","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1055\/s-0031-1271619","volume":"43","author":"M Dittmar","year":"2011","unstructured":"Dittmar M, Libich C, Brenzel T, Kahaly G. Increased familial clustering of autoimmune thyroid diseases. Horm Metab Res. 2011;43:200\u20134.","journal-title":"Horm Metab Res"},{"key":"802_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1741-7015-11-73","volume":"11","author":"J C\u00e1rdenas-Rold\u00e1n","year":"2013","unstructured":"C\u00e1rdenas-Rold\u00e1n J, Rojas-Villarraga A, Anaya J-M. How do autoimmune diseases cluster in families? A systematic review and meta-analysis. BMC Med. 2013;11:1\u201322.","journal-title":"BMC Med"},{"key":"802_CR38","first-page":"45","volume":"5","author":"RS Brown","year":"2013","unstructured":"Brown RS. Autoimmune thyroiditis in childhood. J Clin Res Pediatr Endocrinol. 2013;5:45.","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"802_CR39","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.pcl.2018.04.005","volume":"65","author":"JJY Lee","year":"2018","unstructured":"Lee JJY, Schneider R. Systemic juvenile idiopathic arthritis. Pediatr Clin N Am. 2018;65:691\u2013709.","journal-title":"Pediatr Clin N Am"},{"key":"802_CR40","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1507\/endocrj.EJ18-0243","volume":"65","author":"SA Paschou","year":"2018","unstructured":"Paschou SA, Palioura E, Kothonas F, Myroforidis A, Loi V, Poulou A, et al. The effect of anti-TNF therapy on thyroid function in patients with inflammatory bowel disease. Endocr J. 2018;65:1121\u20135.","journal-title":"Endocr J"},{"key":"802_CR41","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3899\/jrheum.100488","volume":"38","author":"H Raterman","year":"2010","unstructured":"Raterman H, Jamnitski A, Lems W, Voskuyl A, Dijkmans B, Bos W, et al. Improvement of thyroid function in hypothyroid patients with rheumatoid arthritis after 6 months of adalimumab treatment: a pilot study. J Rheumatol. 2010;38:247\u201351.","journal-title":"J Rheumatol"},{"key":"802_CR42","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1007\/s00296-012-2438-9","volume":"33","author":"F Tarhan","year":"2012","unstructured":"Tarhan F, Or\u00fck G, Niflio\u011flu O, Ozer S. Thyroid involvement in ankylosing spondylitis and relationship of thyroid dysfunction with anti-TNF \u03b1 treatment. Rheumatol Int. 2012;33:853\u20137.","journal-title":"Rheumatol Int"},{"key":"802_CR43","doi-asserted-by":"publisher","first-page":"207","DOI":"10.14310\/horm.2002.1310","volume":"10","author":"V Skarpa","year":"2011","unstructured":"Skarpa V, \u039aousta E, Tertipi A, Anyfandakis K, Vakaki M, Dolianiti M, et al. Epidemiological characteristics of children with autoimmune thyroid disease. Hormones. 2011;10:207\u201314.","journal-title":"Hormones."},{"key":"802_CR44","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S1568-9972(01)00016-7","volume":"1","author":"NR Rose","year":"2002","unstructured":"Rose NR, Bonita R, Burek CL. Iodine: an environmental trigger of thyroiditis. Autoimmun Rev. 2002;1:97\u2013103.","journal-title":"Autoimmun Rev"}],"container-title":["Pediatric Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-023-00802-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12969-023-00802-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-023-00802-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T18:02:55Z","timestamp":1677002575000},"score":1,"resource":{"primary":{"URL":"https:\/\/ped-rheum.biomedcentral.com\/articles\/10.1186\/s12969-023-00802-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,21]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["802"],"URL":"https:\/\/doi.org\/10.1186\/s12969-023-00802-1","relation":{},"ISSN":["1546-0096"],"issn-type":[{"value":"1546-0096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,21]]},"assertion":[{"value":"30 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Pharmachild and all participating centers obtained approval from their respective ethics committees and were conducted in accordance with the Declaration of Helsinki. All patients provided written informed consent\/assent based on existing national regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"NR has received honoraria for consultancies or speaker bureaus from the following pharmaceutical companies in the past 3\u2009years: 2 Bridge, Amgen, AstraZeneca, Aurinia, Bayer, Brystol Myers and Squibb, Celgene, inMed, Cambridge Healthcare Research, Domain Therapeutic, EMD Serono, Glaxo Smith Kline, Idorsia, Janssen, Eli Lilly, Novartis, Pfizer, Sobi, UCB. The IRCCS Istituto Giannina Gaslini (IGG), where NR works as full-time public employee has received contributions from the following industries in the last 3\u2009years: Bristol Myers and Squibb, Eli-Lilly, F Hoffmann-La Roche, Novartis, Pfizer, Sobi. This funding has been reinvested for the research activities of the hospital in a fully independent manner, without any commitment with third parties. All other authors declare no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19"}}